EUVIMEDEUVIMED entdecken
Crossref

BODIPY photosensitizers as novel PDT agents against lung cancer cell lines A548 and H1299

Soraia Pedro, Juliana Araújo, António Aguiar, Chrislaura Carmo, Ana C Gonçalves, M Filomena Botelho, Mafalda Laranjo, Abílio J F N Sobral

Bioorganic Chemistry · 2026-11 · 183 · 110628

DOI: 10.1016/j.bioorg.2026.110628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Soraia Pedro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Faculty of Science and Technology, University of Coimbra, 3004-516 Coimbra, Portugal. Hauptthemen laut MEDLINE: Photosensitizing Agents, Boron Compounds, Photochemotherapy, Lung Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Centro de Recursos Naturais e Ambiente, European Regional Development Fund, Programa Operacional Regional do Centro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most commonly diagnosed and lethal cancers, affecting both men and women. While conventional treatments such as surgery, chemotherapy, and radiotherapy offer therapeutic benefits in some cases, their efficacy is often limited by side effects and the development of drug resistance. Consequently, the urgent development of novel, more effective, and less toxic therapeutic agents is needed. Photodynamic therapy (PDT) presents a promising alternative, using a photosensitizer activated by visible light of a specific wavelength. This activation generates reactive oxygen species (ROS), inducing cytotoxic effects and ultimately leading to cell death. Despite this potential, the clinical translation of PDT has been affected by the limited number of FDA-approved drugs and clinical trials. This study investigated the potential of a series of BODIPY derivatives as photosensitizers for use in PDT. Eight BODIPYs, belonging to the boron-dipyrromethenes family and representing an alternative to porphyrin-based photosensitizers, were synthesized and evaluated in vitro against two human lung cancer cell lines, A549 and H1299. Notably, the synthesized compounds exhibited significant antitumour activity, warranting further investigation. The photodynamic response was found to be dependent on both photosensitizer concentration and incubation time. Post-treatment, a marked reduction in viability was observed. Among the synthesized photosensitizers, BDPs 3 and 5 (presenting phenyl and anthracenyl groups in meso position, respectively) emerged as the most promising candidates for in vivo PDT studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsBoron CompoundsPhotochemotherapyLung NeoplasmsAntineoplastic AgentsHumansDrug Screening Assays, AntitumorDose-Response Relationship, DrugStructure-Activity RelationshipMolecular StructureCell Line, TumorCell ProliferationCell SurvivalReactive Oxygen Species

Stichwörter der Autor:innen

BODIPYBoron-dipyrrometheneCancer treatmentLung cancerPhotodynamic therapyPhotosensitizers

Substanzen

Photosensitizing AgentsBoron Compounds4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Physics, Faculty of Science and Technology, University of Coimbra, 3004-516 Coimbra, Portugal.
  • Department of Chemistry, Faculty of Science and Technology, University of Coimbra, 3004-535 Coimbra, Portugal.
  • CERENA-Centro de Recursos Naturais e Ambiente, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.
  • Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment Genetics and Oncobiology (CIMAGO), and Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal;…
  • Department of Chemistry, Faculty of Science and Technology, University of Coimbra, 3004-535 Coimbra, Portugal. Electronic address: asobral@ci.uc.pt.

Förderung

  • Centro de Recursos Naturais e Ambiente
  • European Regional Development Fund
  • Programa Operacional Regional do Centro
  • Programa Operacional Temático Factores de Competitividade
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Pedro, S., Araújo, J., Aguiar, A., Carmo, C., Gonçalves, A. C., Botelho, M. F., Laranjo, M., & Sobral, A. J. F. N. (2026). BODIPY photosensitizers as novel PDT agents against lung cancer cell lines A548 and H1299. Bioorganic Chemistry, 183, 110628. https://doi.org/10.1016/j.bioorg.2026.110628

Vancouver

Pedro S, Araújo J, Aguiar A, Carmo C, Gonçalves AC, Botelho MF, et al. BODIPY photosensitizers as novel PDT agents against lung cancer cell lines A548 and H1299. Bioorganic Chemistry. 2026;183:110628. doi:10.1016/j.bioorg.2026.110628

BibTeX
@article{Pedro2026,
  author = {Pedro, Soraia and Araújo, Juliana and Aguiar, António and Carmo, Chrislaura and Gonçalves, Ana C and Botelho, M Filomena and Laranjo, Mafalda and Sobral, Abílio J F N},
  title = {BODIPY photosensitizers as novel PDT agents against lung cancer cell lines A548 and H1299},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {183},
  pages = {110628},
  doi = {10.1016/j.bioorg.2026.110628}
}
Kostenlos starten →